Companion Animal Specialty Drugs Market
Pet Humanizations Trends to Foment Demand for Companion Animals Specialty Drugs. Here’s More Analysis with Focus on Key Countries Including US, UK, Brazil, Germany, Mexico, and France.
Companion Animal Specialty Drugs Market by Product, Distribution Channel & region - Forecast 2022 - 2032
A Summary of the Companion Animal Specialty Drugs Market Development
[341 Pages Report] The global companion animal specialty drugs market is projected to have a moderate-paced CAGR of 4.21% during the forecast period. The current valuation of the market is US$ 37,624.67 Million in 2022. The market value of the companion animal specialty drugs market is anticipated to reach a high of US$ 56,828.56 Million by the year 2032. A historical CAGR of 5.42% has been recorded by the experts of Future Market Insights for the concerned market. This growth is supported by:
- Rising adoption of pet animals due to growing urbanization and the increase in the number of nuclear families is among the primary market growth factors.
- Growing focus on animal health along with surging demand for pet insurance especially in developed countries will augment the market expansion for companion animal specialty drugs.
- Consistent rise in the number of diseases is generating demand for companion animal drugs.
- Industrial growth can likely be attributed to increasing incidences of zoonotic and food-borne diseases.
- Rising per capita income enables the urban populace to increasingly spend on the treatment of companion animals with diagnosis, vaccines, mitigation, and treatment of diseases like kidney concerns, heartworm, Lyme disease, and more, thereby surging the market share for companion animal specialty drugs.
Although the market is projected to register healthy growth across the estimated study period, it has been revealed by the expert analysts at FMI that certain constraints still prevail in the burgeoning forum. A number of elements were identified while analyzing the market that is likely to hinder the advancement of the companion animal specialty drugs market. They are as follows:
- Risks or chances of side effects, such as mild vomiting, exist after the intake of a drug if it is not suited or administered in excess amounts acts as a key restraint in the global market.
- There is a very high cost associated with companion animals’ specialty drugs, and the middle-class population with pets in low-income countries still remains unaware of such advanced treatments.
Therefore, it is projected that a lack of awareness is likely to curb the penetration of these drugs across certain regions, simultaneously impeding the growth of the concerned market.
Let us know your requirement to get
100% FREE customization
Launch of New Veterinary Drug Products – A Blessing to Boon
As per the analysis of FMI, there is an unprecedented surge witnessed by the global companion animal specialty drugs market, owing to rising ownership of animals and increasing demand for animal-derived products.
New veterinary drugs are being launched in recent years, and the ones identified to gain rapid traction are parasiticides. This drug segment accounted for a market share of 32.2% in the base year. The rising prominence of parasiticides through the forecast period can be attributed to the fact that there is an upsurge in demand for animals and animal-derived products like meat, and the administration of parasiticides enable to boost the quality of meat for consumption and is most sincerely improving the efficiency of livestock and health of companion animals.
At present, technological advances are being made in the administering of this newly launched specialty drug parasiticide such as collars, sprays, and dips, which in turn is expected to boost the market size of companion animal specialty drugs through the projection period.
|
Report Attribute |
Details |
|
Companion Animal Specialty Drugs Market Value (2022) |
US$ 37,624.67 Million |
|
Companion Animal Specialty Drugs Market Anticipated Value (2032) |
US$ 56,828.56 Million |
|
Companion Animal Specialty Drugs Projected Growth Rate (2022-2032) |
4.21% |
A Contrast with the Historical Market Scenario
The global market for companion animal specialty drugs generated huge demand in previous years. The forum registered a gradual CAGR of 5.42% during the period 2017-2021. A number of factors are responsible for this substantial growth.
The expert analysts at FMI have analyzed that the development and approval of new drugs for the treatment of animal diseases is spurring the demand for companion animal specialty drugs. It is identified while studying the market in-details that the rising prevalence of obesity amongst pet dogs and other companion animals has resulted in higher sales of anti-obesity drugs.
Furthermore, significant growth in the number of animal healthcare and NGOs in recent years is also a key aspect majorly contributing to the acceleration of the companion animal specialty drugs. Moreover, some pet diseases also cause serious effects on humans and need to be mitigated for the prevention of infection, which is further identified to boost the market size of companion animal specialty drugs.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystComparative Analysis of Adjacent Markets
Companion Animals Specialty Drugs Market:
|
Differentiating Aspects |
Companion Animals Specialty Drugs Market |
|
CAGR |
5.8% |
|
Market Valuation in 2022 |
US$ 37,624.67 Billion |
|
Projected Market Value in 2032 |
US$ 56,828.56 Billion |
|
Drivers |
|
Veterinary Medicine Market:
|
Differentiating Aspects |
Veterinary Medicine Market |
|
CAGR |
4.6% |
|
Market Valuation in 2022 |
US$ 26,291.34 Million |
|
Projected Market Value in 2032 |
US$ 41,222.05 Million |
|
Drivers |
|
Over-the-Counter Veterinary Drugs Market:
|
Differentiating Aspects |
Over-the-Counter Veterinary Drugs Market |
|
CAGR |
8.1% |
|
Market Valuation in 2022 |
US$ 8.32 Billion |
|
Projected Market Value in 2032 |
US$ 18.14 Billion |
|
Drivers |
|
Category-wise Insights – Identifying the Domineering Segments
Vaccines – By Product Type
The vaccines segment accounted for more than US$ 2.89 billion in the base year. The surging market valuation of this product type can be attributed to:
- Increasing research and development activities in regard to the development of curable vaccines for companion animals is stimulating segment growth.
- Owing to increased R&D, the market has witnessed the emergence of new technologies including recombinant DNA vaccines for dogs in companion animal drugs, thereby fuelling the industry expansion. This type of vaccine is reckoned to provide enhanced disease prevention to pet animals.
Online Veterinary Pharmacies – By Distribution Channel
Technological advances are reported in every sector including animal health, thereby driving the market progression. This segment is anticipated to account for a market share of 37.8% through the forecast period, advancing at a CAGR of 6.8%. The reasons augmenting the growth of this segment are as follows:
- Increasing inclination toward mobile apps that help in tracking animal health habits, and nutritional intake, as well as alerts for pet care services, are likely to foster the market revenue.
- Veterinary online pharmacies provide pet care products, supplements, vaccinations, injections, drugs, and many more, and the ease of availability is a key reason for expanding market shares.
- Integration of digital platforms in veterinary care and the population preference shift towards online services will accelerate the overall market demand.
- High acceptance of e-commerce platforms in emerging economies is also identified to assist in business revenue growth.
Oral Consumption – By Route of Administration
The oral segment accounted for a market valuation of US$ 2.86 billion in the base year. This route of administration is identified to lead through the forecast period due to:
- Increasing preference for companion animals and their ease of consuming specialty drugs.
- Various benefits associated with oral animal drugs such as the reduced risk of acquiring infections, less pain, and requiring no skin penetration support demand for oral dosage.
- Suspensions, solutions, capsules, as well as tablet forms of drugs, are administrated orally in companion animals to improve their health conditions and production.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Regional Insights
Strategic Initiatives Coupled with Rising Digitalization Stir Up the Regional Landscapes
| Country/Region | United States |
| Statistics |
The U.S. companion animal specialty drugs market dominated the global forum in the base year, with more than 88% of revenue shares in the North American region. It is estimated that around 44% of households in the U.S. have a dog and nearly 33% have a cat. |
| Key Propellants |
The market in the U.S is poised to accrue significant gains owing to factors as follows:
|
| Country/Region | Brazil |
| Statistics | The market size for companion animal specialty drugs in Brazil accounted for a valuation of US$ 426 million in the base year. |
| Key Propellants |
The factors owing to the rapid progression of the market in Brazil are as follows:
|
| Country/Region | Germany |
| Statistics |
Germany is projected to advance at a CAGR of 2.4% through the forecast period. The industry profit margin in Germany has increased over the past five years and is expected to have steady growth during the period 2022-2032. |
| Key Propellants |
The market dynamics in Germany are fuelled by the following aspects:
|
Start-up Ecosystem
How are the New Entrants Ceding a Silver Lining to the Forum?
The start-up companies in the companion animal specialty drugs market are continually innovating the drug for better curing the companion animals, paying keen attention to faster recovery. The business models are changing due to evolving market dynamics and the start-up firms are in tandem with the pet humanization trends of the populace, investing heavily in common veterinary drugs.
5 Top Start-ups to Watch For
Wiggles
Funding: US$ 9 Million
This firm is a provider of a wide range of veterinary care products and services. The company provides pet-focused supplements, foods, medicines, and ayurvedic and herbal care products. In addition to selling its products online, the company also provides vet on-call and grooming services.
FidoCure
Funding: US$ 16 Million
Online platform offering health care services for dogs. It connects pet owners and vets. It sends the tumor sample from the original biopsy used to diagnose cancer for DNA sequencing. It identifies genomic mutations and suggests targeted therapy. The vet provides the treatment based on the suggestion given on the platform.
Itch
Funding: US$ 16 Million
Itchpet has developed customized flea treatment products. The user can provide the details via the platform to develop a customized flea and tick treatment product. The products developed are flea, calm, dental, warmer, joint, and ear.
PetMedix
Funding: US$ 37 Million
Developer of monoclonal antibody therapeutics for pets. The company has developed Ky9 and Felyne platforms to generate therapeutic antibodies to treat cancer, inflammation, and other conditions
Nexvet
Funding: US$ 38 Million
Nexvet is focussed on developing novel therapies for companion animal care. Its proprietary PETization platform allows for rapid translation of monoclonal antibodies between species. Current focus is on chronic pain and inflammatory diseases in cats and dogs. Pipeline products include NV-01 for chronic associated with osteoarthritis in dogs, NV-02 for chronic pain in cats and NV-08 targeting inflammation and atopic dermatitis in dogs.
Competitive Landscape
Strong Industry Players Revolutionize & Upscale the Market-o-nomics
The global companion animal specialty drugs market is growing rapidly due to the presence of prominent key players as well as start-ups. Most companies are implementing new strategies for the development of innovative companion animal specialty drugs that cause fewer side effects. Consequently, these factors are anticipated to drive the global companion animal drugs market.
Leaders are focusing on new product launches and adopting inorganic growth strategies to remain competitive and sustain in the market. Partnerships with other players are enhancing product offerings, thus helping the companies to increase their customer base by providing superior quality products.
Recent Developments
- In February 2021, Vetoquinol acquired Canadian rights for the Profender product family from Elanco Animal Health. The acquisition is poised to impact the company’s revenue and offer business development opportunities in untapped economies.
- In August 2020, Elanco Animal Health Incorporated announced that it has acquired Bayer Animal Health. The transaction was valued at USD 6.89 billion. This development helped the company to expand itself in the durable animal health industry.
- In January 2021, Merck Animal Health, known as MSD Animal Health outside the U.S. and Canada, a division of Merck & Co. Inc., announced the collaboration with the Street Dog Coalition to offer medications, vaccines, and treatment for pets of those experiencing homelessness.
- In June 2021, ALR Technologies SG Pvt. Ltd., the diabetes management company announced the establishment of its new business division which will be the world’s first and only CGM for diabetic companion animals, known as ‘ALRT Animal Health Division.
- In 2017, Zoetis emerged as a leading player with the highest share of compassion animal specialty drugs, as the company has a considerable and significant market presence, a diverse portfolio of product offerings, and an acute strategic perspective which includes M&As, such as the acquisition of Abaxis in 2018.
Some of the key companies proliferating in the market are:
- Merck Animal Health (Merck & Co., Inc.)
- Boehringer Ingelheim International GmbH.
- Elanco Animal Health Incorporated
- Virbac S.A.
- Biogenesis Bago SA
- Piramal Group
- Zoetis
- NEOGEN Corporation.
- Vetoquinol S.A.
- Ceva Santé Animale
Key Segments in the Companion Animal Specialty Drugs Market
By Product:
- Antibiotics
- Anti-Inflammatory Drugs
- Parasiticides
- Heartworm
- Behavioral Products
- Nutritional Products
- Anti-Obesity Drugs
- Skin Care Products
- Vaccines
By Distribution Channel:
- Modern Trade
- Online Distribution
- Neighborhood Stores
- Other Retail Format
By Region:
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Frequently Asked Questions
The companion animal specialty drugs market is likely to record a CAGR of 4.21% through 2032.
The companion animal specialty drugs market is currently valued at US$ 37, 624.67 Mn in 2022.
The companion animal specialty drugs market has the potential to reach a valuation of US$ 56,828.56 Mn by 2032.
Demand for vaccines is predicted to remain the highest.
Consumers prefer online veterinary pharmacies to purchase companion animal specialty drugs.
Table of Content
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Companion Animal Drugs Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.2. Market Size and Y-o-Y Growth
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunity
4.4. Global Trends
4.5. PEST Analysis - U.S.
4.6. PEST Analysis - Europe
4.7. Portor's Five Analysis
4.8. Trilateral regulatory harmonization between U.S., EU and Japan on registration of veterinary products
5. Global Companion Animal Drugs Market Analysis and Forecasts, By Product Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Product Type
5.3. Y-o-Y Growth Projections By Product Type
5.4. Market Value Forecast By Product Type, 2021–2031
5.4.1. Antibiotics
5.4.2. Anti-inflammatory Drugs
5.4.3. Parasiticides
5.4.4. Heartworm
5.4.5. Behavioral Products
5.4.6. Nutritional Products
5.4.7. Anti-Obesity Drugs
5.4.8. Skin Care Products
5.4.9. Vaccines
5.5. Market Attractiveness By Product Type
6. Global Companion Animal Drugs Market Analysis and Forecasts, By Distribution Channel
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Distribution Channel
6.3. Y-o-Y Growth Projections By Distribution Channel
6.4. Market Value Forecast By Distribution Channel, 2021–2031
6.4.1. Veterinary Hospitals
6.4.2. Veterinary Clinics
6.4.3. Pharmacies and Drug Stores
6.5. Market Attractiveness By Distribution Channel
7. Global Companion Animal Drugs Market Analysis and Forecasts, By Region
7.1. Basis Point Share (BPS) Analysis By Region
7.2. Y-o-Y Growth Projections By Region
7.3. Market Value Forecast By Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. APEJ
7.3.6. Japan
7.3.7. MEA
7.4. Market Attractiveness By Region
8. North America Companion Animal Drugs Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Country
8.1.2. Y-o-Y Growth Projections By Country
8.2. Market Value Forecast By Product Type, 2021–2031
8.2.1. Antibiotics
8.2.2. Anti-inflammatory Drugs
8.2.3. Parasiticides
8.2.4. Heartworm
8.2.5. Behavioral Products
8.2.6. Nutritional Products
8.2.7. Anti-Obesity Drugs
8.2.8. Skin Care Products
8.2.9. Vaccines
8.3. Market Value Forecast By Distribution Channel, 2021–2031
8.3.1. Veterinary Hospitals
8.3.2. Veterinary Clinics
8.3.3. Pharmacies and Drug Stores
8.4. Market Value Forecast By Country, 2021–2031
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product Type
8.5.2. By Distribution Channel
8.5.3. By Country
8.6. Regional Trends
8.7. Drivers and Restraints: Impact Analysis
9. Latin America Companion Animal Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.2. Market Value Forecast By Product Type, 2021–2031
9.2.1. Antibiotics
9.2.2. Anti-inflammatory Drugs
9.2.3. Parasiticides
9.2.4. Heartworm
9.2.5. Behavioral Products
9.2.6. Nutritional Products
9.2.7. Anti-Obesity Drugs
9.2.8. Skin Care Products
9.2.9. Vaccines
9.3. Market Value Forecast By Distribution Channel, 2021–2031
9.3.1. Veterinary Hospitals
9.3.2. Veterinary Clinics
9.3.3. Pharmacies and Drug Stores
9.4. Market Value Forecast By Country, 2021–2031
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Argentina
9.4.4. Rest of Latin America
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Distribution Channel
9.5.3. By Country
9.6. Regional Trends
9.7. Drivers and Restraints: Impact Analysis
10. Western Europe Companion Animal Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.2. Market Value Forecast By Product Type, 2021–2031
10.2.1. Antibiotics
10.2.2. Anti-inflammatory Drugs
10.2.3. Parasiticides
10.2.4. Heartworm
10.2.5. Behavioral Products
10.2.6. Nutritional Products
10.2.7. Anti-Obesity Drugs
10.2.8. Skin Care Products
10.2.9. Vaccines
10.3. Market Value Forecast By Distribution Channel, 2021–2031
10.3.1. Veterinary Hospitals
10.3.2. Veterinary Clinics
10.3.3. Pharmacies and Drug Stores
10.4. Market Value Forecast By Country, 2021–2031
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Nordics
10.4.7. Benelux
10.4.8. Rest of Western Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Distribution Channel
10.5.3. By Country
10.6. Regional Trends
10.7. Drivers and Restraints: Impact Analysis
11. Eastern Europe Companion Animal Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.2. Market Value Forecast By Product Type, 2021–2031
11.2.1. Antibiotics
11.2.2. Anti-inflammatory Drugs
11.2.3. Parasiticides
11.2.4. Heartworm
11.2.5. Behavioral Products
11.2.6. Nutritional Products
11.2.7. Anti-Obesity Drugs
11.2.8. Skin Care Products
11.2.9. Vaccines
11.3. Market Value Forecast By Distribution Channel, 2021–2031
11.3.1. Veterinary Hospitals
11.3.2. Veterinary Clinics
11.3.3. Pharmacies and Drug Stores
11.4. Market Value Forecast By Country, 2021–2031
11.4.1. Russia
11.4.2. Poland
11.4.3. Rest of Eastern Europe
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By Distribution Channel
11.5.3. By Country
11.6. Regional Trends
11.7. Drivers and Restraints: Impact Analysis
12. APEJ Companion Animal Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.2. Market Value Forecast By Product Type, 2021–2031
12.2.1. Antibiotics
12.2.2. Anti-inflammatory Drugs
12.2.3. Parasiticides
12.2.4. Heartworm
12.2.5. Behavioral Products
12.2.6. Nutritional Products
12.2.7. Anti-Obesity Drugs
12.2.8. Skin Care Products
12.2.9. Vaccines
12.3. Market Value Forecast By Distribution Channel, 2021–2031
12.3.1. Veterinary Hospitals
12.3.2. Veterinary Clinics
12.3.3. Pharmacies and Drug Stores
12.4. Market Value Forecast By Country, 2021–2031
12.4.1. China
12.4.2. India
12.4.3. Australia & New Zealand
12.4.4. ASEAN
12.4.5. Rest of APEJ
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By Distribution Channel
12.5.3. By Country
12.6. Regional Trends
12.7. Drivers and Restraints: Impact Analysis
13. Japan Companion Animal Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Absolute $ Opportunity (US$ Mn), 2021–2031
13.2. Market Value Forecast By Product Type, 2021–2031
13.2.1. Antibiotics
13.2.2. Anti-inflammatory Drugs
13.2.3. Parasiticides
13.2.4. Heartworm
13.2.5. Behavioral Products
13.2.6. Nutritional Products
13.2.7. Anti-Obesity Drugs
13.2.8. Skin Care Products
13.2.9. Vaccines
13.3. Market Value Forecast By Distribution Channel, 2021–2031
13.3.1. Veterinary Hospitals
13.3.2. Veterinary Clinics
13.3.3. Pharmacies and Drug Stores
13.4. Market Attractiveness Analysis
13.4.1. By Product Type
13.4.2. By Distribution Channel
13.5. Regional Trends
13.6. Drivers and Restraints: Impact Analysis
14. MEA Companion Animal Drugs Market Analysis and Forecast
14.1. Introduction
14.1.1. Basis Point Share (BPS) Analysis By Country
14.1.2. Y-o-Y Growth Projections By Country
14.2. Market Value Forecast By Product Type, 2021–2031
14.2.1. Antibiotics
14.2.2. Anti-inflammatory Drugs
14.2.3. Parasiticides
14.2.4. Heartworm
14.2.5. Behavioral Products
14.2.6. Nutritional Products
14.2.7. Anti-Obesity Drugs
14.2.8. Skin Care Products
14.2.9. Vaccines
14.3. Market Value Forecast By Distribution Channel, 2021–2031
14.3.1. Veterinary Hospitals
14.3.2. Veterinary Clinics
14.3.3. Pharmacies and Drug Stores
14.4. Market Value Forecast By Country, 2021–2031
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of MEA
14.5. Market Attractiveness Analysis
14.5.1. By Product Type
14.5.2. By Distribution Channel
14.5.3. By Country
14.6. Regional Trends
14.7. Drivers and Restraints: Impact Analysis
15. Competition Landscape
15.1. Competition Dashboard
15.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments and SWOT Analysis)
15.2.1. Zoetis, Inc.
15.2.1.1. Overview
15.2.1.2. Financials
15.2.1.3. Strategy
15.2.1.4. Recent Developments and SWOT Analysis
15.2.2. Merck and Co., Inc.
15.2.2.1. Overview
15.2.2.2. Financials
15.2.2.3. Strategy
15.2.2.4. Recent Developments and SWOT Analysis
15.2.3. Bayer AG
15.2.3.1. Overview
15.2.3.2. Financials
15.2.3.3. Strategy
15.2.3.4. Recent Developments and SWOT Analysis
15.2.4. Elanco
15.2.4.1. Overview
15.2.4.2. Financials
15.2.4.3. Strategy
15.2.4.4. Recent Developments and SWOT Analysis
15.2.5. Boehringer Ingelheim Animal Health
15.2.5.1. Overview
15.2.5.2. Financials
15.2.5.3. Strategy
15.2.5.4. Recent Developments and SWOT Analysis
15.2.6. Ceva Santé Animale
15.2.6.1. Overview
15.2.6.2. Financials
15.2.6.3. Strategy
15.2.6.4. Recent Developments and SWOT Analysis
16. Assumptions and Acronyms Used
17. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product Type, 2022 - 2032
Table 02: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032
Table 03: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Region, 2022 - 2032
Table 04: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2022 - 2032
Table 05: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032
Table 06: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032
Table 07: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2022 - 2032
Table 08: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032
Table 09: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032
Table 10: Western Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2022 - 2032
Table 11: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032
Table 12: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032
Table 13: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2022 - 2032
Table 14: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032
Table 15: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032
Table 16: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2022 - 2032
Table 17: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032
Table 18: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032
Table 19 : Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast, 2022 - 2032
Table 20: Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032
Table 21: Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032
Table 22: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2022 - 2032
Table 23: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2022 - 2032
Table 24: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Companion Animal Drugs Market Size (US$ Mn) By Product Type, 2021 & 2031
Figure 02: Global Companion Animal Drugs Market Share Analysis (%) By Product Type, 2021 & 2031
Figure 03: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Product Type, 2022 - 2032
Figure 04: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Antibiotics Segment, 2022 - 2032
Figure 05: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Anti-inflammatory Drugs Segment, 2022 - 2032
Figure 06: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Parasiticides Segment, 2022 - 2032
Figure 07: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Heartworm Segment, 2022 - 2032
Figure 08: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Behavioral Products Segment, 2022 - 2032
Figure 09: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) Nutritional Products Segment, 2022 - 2032
Figure 10: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Anti-Obesity Drugs Segment, 2022 - 2032
Figure 11: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Skin Care Products Segment, 2022 - 2032
Figure 12: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Vaccines Segment, 2022 - 2032
Figure 13: Global Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032
Figure 14 : Global Companion Animal Drugs Market Size (US$ Mn) By Distribution Channel, 2021 & 2031
Figure 15: Global Companion Animal Drugs Market Share by Distribution Channel, 2022 - 2032
Figure 16: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Distribution Channel, 2022 - 2032
Figure 17: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Veterinary Hospitals Segment, 2022 - 2032
Figure 18: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Veterinary Clinics Segment, 2022 - 2032
Figure 19: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Pharmacies and Drug Stores Segment, 2022 - 2032
Figure 20: Global Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032
Figure 21: Global Companion Animal Drugs Market Size (US$ Mn) By Region, 2021 & 2031
Figure 22: Global Companion Animal Drugs Market Share Analysis (%) By Region, 2021 & 2031
Figure 23: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Region, 2022 - 2032
Figure 24: North America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 25: Latin America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 26: Western Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 27: Eastern Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 28: APEJ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 29: Japan Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 30: MEA Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 31: Global Companion Animal Drugs Market Attractiveness Analysis By Region, 2022 - 2032
Figure 32: North America Companion Animal Drugs Market Share Analysis (%) By Country, 2017 - 2027
Figure 33: North America Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2022 - 2032
Figure 34: The U.S. Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),
Figure 35: Canada Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),
Figure 36: North America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032
Figure 37: North America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032
Figure 38: Global Companion Animal Drugs Market Attractiveness Analysis By Country, 2022 - 2032
Figure 39: Latin America Companion Animal Drugs Market Share Analysis (%) By Country, 2022 - 2032
Figure 40: Latin America Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2022 - 2032
Figure 41: Brazil Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 42: Mexico Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 43: Argentina Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 44: Rest of Latin America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 45: Latin America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032
Figure 46: Latin America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032
Figure 47: Latin America Companion Animal Drugs Market Attractiveness Analysis By Country, 2022 - 2032
Figure 48: Western Europe Companion Animal Drugs Market Share Analysis (%) By Country, 2021 & 2031
Figure 49: Western Europe Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2022 - 2032
Figure 50: U.K. Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 51: Germany Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 52: France Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),
Figure 53: Italy Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 54: Spain Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 55: Nordic Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),
Figure 56: Benelux Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 57: Rest of Western Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 58: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032
Figure 59: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032
Figure 60: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Country, 2022 - 2032
Figure 61: Eastern Europe Companion Animal Drugs Market Share Analysis (%) By Country, 2022 - 2032
Figure 62: Eastern Europe Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2022 - 2032
Figure 63: Russia Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 64: Poland Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 65: Rest of Eastern Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 66: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032
Figure 67: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032
Figure 68: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Country, 2022 - 2032
Figure 69: APEJ Companion Animal Drugs Market Share Analysis (%) By Country, 2017 & 2027
Figure 70: APEJ Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2022 - 2032
Figure 71: China Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 72: India Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 73: A&NZ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 74: ASEAN Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 75: Rest of APEJ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 76: APEJ Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032
Figure 77: APEJ Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032
Figure 78: APEJ Companion Animal Drugs Market Attractiveness Analysis By Country, 2022 - 2032
Figure 79: Japan Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 80: Japan Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032
Figure 81: Japan Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032
Figure 82: MEA Companion Animal Drugs Market Share Analysis (%) By Country, 2021 & 2031
Figure 83: MEA Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2022 - 2032
Figure 84: GCC countries Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 85: South Africa Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 86: Rest of MEA Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2022 - 2032
Figure 87: North America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2022 - 2032
Figure 88: North America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2022 - 2032
Figure 89: MEA Companion Animal Drugs Market Attractiveness Analysis By Country, 2022 - 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
